P3 Health Partners Inc. (PIII)
PIII trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1832511/000183251126000011/0001832511-26-000011-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | PIII on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001832511 |
| SEC industry code | Services-Health Services |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.5B |
| Net income | -$147.9M |
| Operating income | -$270.3M |
| Net margin | -10.1% |
| Operating margin | -18.5% |
| Revenue growth | -2.8% |
| Cash | $25.0M |
| Total assets | $656.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.0× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "As a result of these matters, substantial doubt exists about the Company's ability to continue as a going concern for one year after the date the financial statements are issued." | 10-Q 2026-11-09 |
| Cash and burn | $43.9M cash; operating cash flow -$28.9M a quarter. | Report 2026-09-30 |
| Shares outstanding | 7,261,277 (2026-11-04); 7,205,589 a year earlier. | Cover page 2026-11-04 |
| Reverse splits, 3 years | 1; latest 1-for-50 on 2025-04-14 | Source 2025-04-14 |
| Shelf and offerings, 12 months | 1 S-3/F-3 shelf filings; 0 424B5 takedowns | Latest 2026-10-15 |
| Exchange deficiency notices, 12 months | 2 (8-K item 3.01) | 8-K 2026-05-26 |
| Auditor | BDO USA, P.C., Las Vegas, Nevada, United States | PCAOB Form AP 2026-03-27 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $824K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $396.3M | $15.6M | -$685K | $43.9M | $121.9M | $1.6B | 10-Q 2026-11-09 |
| Q2 2026 2026-06-30 | $386.4M | $7.4M | -$61.9M | $21.3M | $120.3M | $1.5B | 10-Q 2026-08-10 |
| Q1 2026 2026-03-31 | $386.4M | $1.2M | -$27.5M | $25.5M | $311.8M | $1.5B | 10-Q 2026-05-14 |
| Q4 2025 2025-12-31 | $384.8M | -$75.5M | -$25.7M | $25.0M | $273.4M | $1.5B | 10-K 2026-03-26 |
| Q3 2025 2025-09-30 | $345.3M | -$31.6M | -$15.4M | $37.7M | $252.9M | $1.4B | 10-Q 2026-11-09 |
| Q2 2025 2025-06-30 | $355.8M | -$20.4M | -$16.6M | $38.6M | $182.4M | $1.5B | 10-Q 2026-08-10 |
| Q1 2025 2025-03-31 | $373.2M | -$20.5M | -$33.5M | $40.1M | $171.9M | $1.5B | 10-Q 2026-05-14 |
| Q4 2024 2024-12-31 | $370.7M | -$58.6M | -$57.2M | $38.8M | $108.9M | $1.5B | 10-K 2026-03-26 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3 | 2026-10-15 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-11-09 |
| Latest current report | 8-K | 2026-11-09 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 405 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -32.5% |
| 1 month | -33.0% |
| 3 months | -75.4% |
| Year to date | -22.6% |
| 1 year | -61.4% |
| From 52-week high | -83.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| PIIIW | P3 Health Partners Inc. Warrant | $0.0053 |
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| DCGO | DocGo Inc. | $0.1899 | -8.53% | $18.8M |
| CCM | Concord Medical Services Holdings Limited | $3.59 | -0.83% | $15.6M |
| ALPS | ALPS Group Inc Ordinary Share | $1.15 | -3.36% | $36.4M |
| EUDA | EUDA Health Holdings Limited | $15.32 | -1.45% | $45.9M |
| AIRS | AirSculpt Technologies Inc. | $0.7000 | -16.37% | $51.7M |
| BMGL | Basel Medical Group Ltd | $0.3023 | -35.68% | $4.1M |
| NAKA | Nakamoto Inc. | $4.59 | -8.20% | $84.2M |
| LFMD | LifeMD Inc. | $1.85 | -15.72% | $89.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier